Showing 81
to 90
of 1,241 results
-
12 Dec 2014 -
The Commerce Commission has granted clearance to Mylan Inc. to acquire the Established Pharmaceuticals Division of Abbott Laboratories, Inc.
-
21 Aug 2014 -
The Commerce Commission has granted clearance to CDC Pharmaceuticals Limited (CDC) and Pharmacy Wholesalers (Central) Limited (PWL Central) to merge their respective businesses.
-
27 Nov 2014 -
The Commission has granted clearance to GlaxoSmithKline (GSK) to acquire the consumer healthcare business of Novartis AG (Novartis). As a result of the acquisition, the consumer healthcare businesses of both parties will be merged into a new, GSK
-
17 Jun 2014 -
On the day of significant changes to consumer law coming into effect, the Commerce Commission is encouraging New Zealanders to make sure they know their consumer rights.
-
7 Feb 2014 -
The Commerce Commission has today released a paper which outlines the proposed process for pricing Chorus’ wholesale broadband – the unbundled bitstream access (UBA) service - according to the ‘Final Pricing Principle’ in the
-
3 Dec 2014 -
The Commerce Commission has reached a $19 million settlement with ANZ Bank New Zealand Limited (ANZ) in relation to the marketing, promotion and sale of interest rate swaps to rural customers between 2005 and 2009.
-
8 Apr 2014 -
The Commerce Commission has completed its long running case involving the cardboard packaging cartel between Visy Board Pty Ltd (Visy) and Amcor Ltd with the final defendant, Mr James Hodgson, being ordered to pay a penalty of $60,000 and costs of
-
10 Oct 2014 -
The Commerce Commission has received an application from Mylan Inc. seeking clearance to acquire the Established Pharmaceuticals Division of Abbott Laboratories Inc.
-
8 Apr 2014 -
The Commerce Commission welcomes today’s High Court judgment in relation to Chorus’ appeal against the Commission’s November 2013 decision setting cost-based prices for the unbundled bitstream access (UBA) service.
-
2 Apr 2014 -
The Commerce Commission has announced that it is currently assessing new information received concerning the banks involved in the interest rate swaps investigation.
